Your browser doesn't support javascript.
loading
High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium.
Calcoen, Bas; Callewaert, Nico; Vandenbulcke, Aline; Kerstens, Winnie; Imbrechts, Maya; Vercruysse, Thomas; Dallmeier, Kai; Van Weyenbergh, Johan; Maes, Piet; Bossuyt, Xavier; Zapf, Dorinja; Dieckmann, Kersten; Callebaut, Kim; Thibaut, Hendrik Jan; Vanhoorelbeke, Karen; De Meyer, Simon F; Maes, Wim; Geukens, Nick.
Afiliación
  • Calcoen B; Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, 8500 Kortrijk, Belgium.
  • Callewaert N; AZ Groeninge Hospital, Department of Laboratory Medicine, 8500 Kortrijk, Belgium.
  • Vandenbulcke A; Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, 8500 Kortrijk, Belgium.
  • Kerstens W; Laboratory of Virology and Chemotherapy, Translational Platform Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, KU Leuven Rega Institute, 3000 Leuven, Belgium.
  • Imbrechts M; PharmAbs, the KU Leuven Antibody Center, KU Leuven, 3000 Leuven, Belgium.
  • Vercruysse T; Laboratory of Virology and Chemotherapy, Translational Platform Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, KU Leuven Rega Institute, 3000 Leuven, Belgium.
  • Dallmeier K; Laboratory of Virology, Molecular Vaccinology and Vaccine Discovery, Department of Microbiology, Immunology and Transplantation, KU Leuven Rega Institute, 3000 Leuven, Belgium.
  • Van Weyenbergh J; Laboratory for Clinical and Epidemiological Virology, KU Leuven Rega Institute, 3000 Leuven, Belgium.
  • Maes P; Laboratory for Clinical and Epidemiological Virology, KU Leuven Rega Institute, 3000 Leuven, Belgium.
  • Bossuyt X; Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium.
  • Zapf D; Department of Laboratory Medicine, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Dieckmann K; Institut für Experimentelle Immunologie, EUROIMMUN Medizinische Labordiagnostika AG, 23552 Lübeck, Germany.
  • Callebaut K; Institut für Experimentelle Immunologie, EUROIMMUN Medizinische Labordiagnostika AG, 23552 Lübeck, Germany.
  • Thibaut HJ; AZ Groeninge Hospital, Department of Laboratory Medicine, 8500 Kortrijk, Belgium.
  • Vanhoorelbeke K; Laboratory of Virology and Chemotherapy, Translational Platform Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, KU Leuven Rega Institute, 3000 Leuven, Belgium.
  • De Meyer SF; Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, 8500 Kortrijk, Belgium.
  • Maes W; PharmAbs, the KU Leuven Antibody Center, KU Leuven, 3000 Leuven, Belgium.
  • Geukens N; Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, 8500 Kortrijk, Belgium.
Viruses ; 14(6)2022 06 09.
Article en En | MEDLINE | ID: mdl-35746728
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Viruses Año: 2022 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Viruses Año: 2022 Tipo del documento: Article País de afiliación: Bélgica